Archive

Year: 2024 | 2023 | 2022 | 2017 | 2015


Conference MEFANET 2023

18. 11. 2023

Daniel Schwarz chaired this year's MEFANET conference, which took place in Košice on November 7-8 2023.

It is a matter of course for us at the IBA to be helpful and to help others.

5. 9. 2023

This year we put our time and energy into helping the Logo Civic Association.

Reflecting on an Inspiring CZECRIN Annual Conference

26. 6. 2023

Last week, Daniel Schwarz attended the CZECRIN annual conference, which took place in St. Anne's University Hospital Brno. He was very interested in the interactive session dedicated to CTIS, expertly mediated by members of ethics committees from various institutions, as well as the discussion around decentralized clinical trials.

Petr Brabec and Daniel Schwarz accepted the award at the Business Research Forum 2023

31. 5. 2023

We have been a spin-off of Masaryk University Brno for almost 10 years and are proud to be recognized on the market as a well-established company providing CRO services and Data Management.

Petr Brabec and Daniel Schwarz accepted the award at the Business Research Forum 2023. We thank everyone who supported us on this journey and we look forward to continuing our partnership with Masaryk University in the years to come.

TREAT-NMD CONFERENCE

24. 2. 2023

Colleagues Marika Chrápavá and Lenka Mokrá went to Vancouver, Canada for "neurological registries" at the TREAT-NMD CONFERENCE.
The 7th TREAT-NMD International Conference was held on December 7-9, 2022


Back

The Institute of Biostatistics and Analyses is an investigator of the project “Extending services portfolio of an information system for the data management in clinical research”. The project is supported by the OP EIC from the European Union funds.

Main objective of the project is the development of a platform for composition of information systems focused on data management and data mining in the field of pharmaceutical industry and life sciences. Offer of digital services based on a developed and validated information system will make reliable analytical models accessible to the companies for their decision-making and precise information sources for regulatory bodies. The project steps out of a laboratory environment of clinical trials and focuses on the evidence supported by real-world data.

Institute of Biostatistics and Analyses, Ltd.